Honestly I am very concerned about the filing today. I have been a faithful long for over 18 months and am trying to keep a positive outlook, but we just keep seeming to hit one brick wall after another. Losing the potential isradripine market stinks. Not anticipating being cash flow positive is another turn around from previous comments. I am still in this for the long haul with y core position, but am getting a little more skeptical than I have been in a while. I hope this turns around sooner than later. GLTA
(0)
(0)
Elite Pharmaceuticals Inc (ELTP) Stock Research Links